SCHEMBL10620884

SCHEMBL10620884

C[C@H]1OC(OC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.78

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ AMY1A P0DUB6 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ SELE P16581 1/20 0.48
▸ PTPN1 P18031 1/20 0.48
▸ STAT3 P40763 4/20 0.46
▸ SYNJ2 O15056 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ TYR P14679 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4265622 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL17072443 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL6914548 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL1096608 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL7545171 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL301721 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL17072438 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL9939094 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL2454313 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT
SCHEMBL29572443 1.00 AMY1A (0.55) AMY1AL3MBTL1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230255989-A1 GLYCAN COMPOSITIONS AND USES THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2023-08-17 — — US disclosed
US-11229660-B2 Glycan therapeutics and method of treating conditions associated with TMAO KALEIDO BIOSCIENCES, INC. (US) 2022-01-25 — — US disclosed
US-20210137956-A1 GLYCAN COMPOSITIONS AND USES THEREOF HERCULES CAPITAL, INC. 2021-05-13 — — US disclosed
US-20210113596-A1 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF KALEIDO BIOSCIENCES, INC. (US) 2021-04-22 — — US disclosed
US-10881676-B2 Glycan therapeutics and related methods thereof KALEIDO BIOSCIENCES, INC. (US) 2021-01-05 — — US disclosed
US-10702542-B2 Glycan therapeutics and related methods thereof KALEIDO BIOSCIENCES, INC. (US) 2020-07-07 — — US disclosed
US-20200093845-A1 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF HERCULES CAPITAL, INC. 2020-03-26 — — US disclosed
US-20200093851-A1 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF HERCULES CAPITAL, INC. 2020-03-26 — — US disclosed
US-10314853-B2 Glycan therapeutics and related methods thereof KALEIDO BIOSCIENCES, INC. (US) 2019-06-11 — — US disclosed
US-20180235987-A1 GLYCAN COMPOSITIONS AND USES THEREOF HERCULES CAPITAL, INC. 2018-08-23 — — US disclosed
US-PP6379-P Geranium plant \"Siren\ RESEARCH CORPORATION (US) 1988-11-08 — — US disclosed
US-PP6378-P Geranium plant \"Calypso\ RESEARCH CORPORATION (US) 1988-11-08 — — US disclosed
US-PP6247-P Geranium plant \"Helen\ RESEARCH CORPORATION (US) 1988-08-16 — — US disclosed
US-PP6220-P Geranium plant \"Cassandra\ RESEARCH CORPORATION (US) 1988-07-12 — — US disclosed
US-PP6218-P Geranium plant \"Ben Franklin\ RESEARCH CORPORATION (US) 1988-07-12 — — US disclosed
US-PP6219-P Geranium plant \"Paris\ RESEARCH CORPORATION (US) 1988-07-12 — — US disclosed
US-PP6065-P Variety of geranium named Valerie DENHOLM SEEDS (US) 1987-12-22 — — US disclosed
US-PP6063-P Variety of geranium named Claret DENHOLM SEEDS (US) 1987-12-22 — — US disclosed
US-PP6064-P Variety of geranium named Victoria DENHOLM SEEDS (US) 1987-12-22 — — US disclosed
US-PP6066-P Variety of geranium named Diplomat DENHOLM SEEDS (US) 1987-12-22 — — US disclosed
Send feedback